IL214785A0 - Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof - Google Patents
Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereofInfo
- Publication number
- IL214785A0 IL214785A0 IL214785A IL21478511A IL214785A0 IL 214785 A0 IL214785 A0 IL 214785A0 IL 214785 A IL214785 A IL 214785A IL 21478511 A IL21478511 A IL 21478511A IL 214785 A0 IL214785 A0 IL 214785A0
- Authority
- IL
- Israel
- Prior art keywords
- acid derivatives
- nitric oxide
- therapeutic uses
- dihydrolipoic acid
- dihydrolipoic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C313/08—Sulfenic acids; Derivatives thereof
- C07C313/18—Sulfenamides
- C07C313/36—Sulfenamides having nitrogen atoms of sulfenamide groups further bound to other hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2010/024772 WO2010096677A2 (en) | 2009-02-17 | 2010-02-19 | Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL214785A0 true IL214785A0 (en) | 2011-11-30 |
Family
ID=45774361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL214785A IL214785A0 (en) | 2010-02-19 | 2011-08-22 | Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP2013507325A (en) |
KR (1) | KR20120107076A (en) |
AU (1) | AU2010215871A1 (en) |
CA (1) | CA2777743A1 (en) |
IL (1) | IL214785A0 (en) |
RU (1) | RU2012103757A (en) |
-
2010
- 2010-02-19 CA CA2777743A patent/CA2777743A1/en not_active Abandoned
- 2010-02-19 RU RU2012103757/04A patent/RU2012103757A/en unknown
- 2010-02-19 KR KR1020127012599A patent/KR20120107076A/en not_active Application Discontinuation
- 2010-02-19 JP JP2011552969A patent/JP2013507325A/en active Pending
- 2010-02-19 AU AU2010215871A patent/AU2010215871A1/en not_active Abandoned
-
2011
- 2011-08-22 IL IL214785A patent/IL214785A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2777743A1 (en) | 2010-08-26 |
KR20120107076A (en) | 2012-09-28 |
JP2013507325A (en) | 2013-03-04 |
RU2012103757A (en) | 2013-12-20 |
AU2010215871A1 (en) | 2012-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1900017I1 (en) | Cyclic boronic acid ester derivatives and therapeutic uses thereof | |
IL250259A0 (en) | Compositions comprising ursolic acid and derivatives thereof and uses thereof | |
HK1192879A1 (en) | Substituted 1-benzylcycloalkylcarboxlic acids and use thereof 1- | |
HK1187049A1 (en) | Bisaryl-bonded aryltriazolones and use thereof | |
HK1178538A1 (en) | Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals - 3-- | |
PL2605757T3 (en) | Nalbuphine-based formulations and uses thereof | |
PT2521445T (en) | Formulation and use thereof | |
IL236965B (en) | Derivatives of 5-aminolevulinic acid and uses thereof | |
IL226003A0 (en) | Trans-2-decenoic acid derivative and pharmaceutical agent containing the same | |
PT2563806E (en) | Human leukolectins and uses thereof | |
EP2864345A4 (en) | Particle-nucleic acid conjugates and therapeutic uses related thereto | |
PL2648715T3 (en) | Carnosine-hyaluronic acid mixtures and their use | |
EP2542967A4 (en) | High and low value application state | |
HK1184779A1 (en) | Novel compound and medical use thereof | |
EP2539317A4 (en) | Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof | |
HK1162526A1 (en) | Glp-1 derivatives and uses thereof glp-1 | |
IL214785A0 (en) | Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof | |
GB201012660D0 (en) | Inhaler and formulation | |
EP2657236A4 (en) | Novel 2-alkynyl-n9-propargyladenine and medicinal use thereof | |
GB201005712D0 (en) | Medicaments and their manufacture |